The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Singh & Associates Founder – Manoj K Singh Advocates and Solicit

E-337, EAST OF KAILASH, NEW DELHI 110065, INDIA
Tel:
Work +91 11 46667000
Email:
Web:
www.singhassociates.in

Firm Rankings

India

Corporate and M&A
Corporate and M&A - ranked: tier 3

Singh & Associates Founder – Manoj K Singh Advocates and Solicitors

Singh & Associates Founder – Manoj K Singh Advocates and Solicitors advises domestic and international clients on company formations and tax structuring, mergers and acquisitions, due diligence and regulatory approvals. The group recently advised The Leschaco Group on a share purchase agreement with Escombe Lambert, and also assisted Udayan Care with various issues surrounding governance structure, board policies and appraisal mechanisms, among other matters. Gunita Pahwa heads the transactional practice, and Daizy Chawla is the key contact for corporate and taxation issues.

[back to top]

Dispute resolution
Dispute resolution - ranked: tier 2

Singh & Associates Founder – Manoj K Singh Advocates and Solicitors

The ‘prompt’ team at Singh & Associates Founder – Manoj K Singh Advocates and Solicitors provides ‘efficient and practical advice’, handling a vast array of disputes in the banking and finance, white-collar crime, real estate and intellectual property sectors, among others. Founding partner Manoj Singh is ‘a pragmatic lawyer who understands the difficulties faced by businesses’; Singh is currently representing Novartis in an ongoing investigation into parenteral use of inactive pharmaceutical ingredients. Vijay Singh is the other key figure, and is highly experienced in Supreme Court matters.

[back to top]

Intellectual property
Intellectual property - ranked: tier 4

Singh & Associates Founder – Manoj K Singh Advocates and Solicitors

Daizy Chawla leads the team at Singh & Associates Founder – Manoj K Singh Advocates and Solicitors, and advises Dennemeyer on a number of IP aspects, including its patent annuity portfolio and infringement issues. Founding partner and head of litigation Manoj Singh is recommended for IP disputes, and senior principal associate Shrimant Singh joined from Remfry & Sagar.

[back to top]

Labour and employment
Labour and employment - ranked: tier 4

Singh & Associates Founder – Manoj K Singh Advocates and Solicitors

Led by Gunita Pahwa and Daizy Chawla, the team at Singh & Associates Founder – Manoj K Singh Advocates and Solicitors advises on state and central labour and employment law, internal disciplinary proceedings, disputes, regulatory compliance issues, contracts, and legal notices. Clients include Era Infra Engineering, FircoSoft and Clinipace Worldwide.

[back to top]

Tax
Tax - ranked: tier 4

Singh & Associates Founder – Manoj K Singh Advocates and Solicitors

At Singh & Associates Founder – Manoj K Singh Advocates and Solicitors, Daizy Chawla represented Dunar Foods in an excise matter before the Supreme Court. Gunita Pahwa is another key name. Henry Ford Health System is also a client.

[back to top]

Further information on Singh & Associates Founder – Manoj K Singh Advocates and Solicit

Please choose from this list to view details of what we say about Singh & Associates Founder – Manoj K Singh Advocates and Solicit in other jurisdictions.

India

Offices in New Delhi

Search News and Articles

Legal Developments by:
Singh & Associates Founder – Manoj K Singh Advocates and Solicit

  • BRAND-JACKING

    WHAT IS BRANDJACKING?
    - Singh & Associates Advocates & Sol

Legal Developments in India

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

  • BRAND-JACKING

    WHAT IS BRANDJACKING?
    - Singh & Associates Advocates & Sol

  • Post Marketing Surveillance of Drugs

    Post marketing surveillance is performed after market approval/clinical trials of drugs in India. The regulatory framework for conducting clinical trials of drugs is provided under the Drugs and Cosmetics Act, 1940 (“ Act ”) and the Drugs and Cosmetics Rules, 1945 (“ Rules ”). Further, Part X-A and Schedule Y of the Rules specifically deal with the statutory provisions applicable for clinical trial of drugs in India. Schedule Y divides Clinical trial of drugs into 4 Phases, namely, Human Pharmacology (Phase-I), Therapeutic exploratory trials (Phase-II), Therapeutic confirmatory trials (Phase III) and Post Marketing Trials (Phase-IV).
    - Singh & Associates Advocates & Sol

  • Protection of Biotechnology under Indian Laws

    According to the eighth annual survey conducted by the Association of Biotechnology-Led Enterprises (ABLE) and Bio Spectrum, the Indian biotech industry grew threefold in just five years to report revenues of US$ 3 billion in 2009-10, a rise of 17 per cent over the previous year. Maintaining the momentum of the previous years, the Indian biotech industry grew 16.28 per cent in FY2014; the total industry size was US$ 5 billion at the end of the financial year and it reached US$ 7 billion in FY2015. Fast-paced growth is likely to continue; the industry is expected to increase in size to USD11.6 billion by 2017, driven by a range   of factors such as growing demand, intensive R & D activities and strong government initiatives ( http://www.ibef.org/industry/biotechnology-india.aspx )
    - Singh & Associates Advocates & Sol

  • Cabinet Approves India’s IPR Policy - “Creative India; Innovative India: रचनात्म??

    The Union Cabinet on 13 May 2016 approved the National Intellectual Property Right (IPR) policy roadmap ( http://dipp.gov.in/English/Schemes/Intellectual_Property_Rights/National_IPR_Policy_12.05.2016.pdf ) to foster creativity and innovation, promote entrepreneurship and enhance socio development, enhance access to healthcare, food security and environmental protection. The Policy recognizes the abundance of creative and innovative energies that flow in India, and the need to tap into and channelize these energies towards a better and brighter future for all.
    - Singh & Associates Advocates & Sol

  • Real Estate - India

    Real Estate - India
    - I.L.A. Pasrich & Company

  • SEBI’s Jurisdiction | Analysis of the Supreme Court judgment in the Sahara case

    The Securities and Exchange Board of India (SEBI) is responsible for investor protection and development and regulation of the securities market in India. The scope of SEBI’s jurisdiction over the issue of securities by public companies is an important issue. This issue was recently considered by the Supreme Court in Sahara India Real Estate Corporation Ltd. and Ors. v. Securities and Exchange Board of India and Anr., MANU/SC/0702/2012; (2012) 8 SCALE 101. This article analyses this judgment and its implications.
    - Khaitan & Co.

  • Mainstreaming the Alternative: Issuance of NCDs

    Debt financing is a significant means for corporates to raise capital. Indian regulators have taken a number of steps to deepen the Indian debt market. Permission has been granted to foreign institutional investors (FIIs) and qualified foreign investors (QFIs) to invest in non-convertible debentures (NCDs) issued by Indian companies. This article summarises the legal and regulatory requirements for Indian companies to issue NCDs to FIIs and QFIs.
    - Khaitan & Co.

  • Options – Not a Part of History Yet

    At the time when India is completing two decades of the economic liberalization there are several laurels which the policymakers can boast of.   The path-breaking shift from the license-raj to a regime focusing on regulation introduced by the Government of India in the landmark year 1991 have been continued through further economic reforms and the same has also found support from the regulators and the market players.
    - kanga & co

  • Liberalization Back on Track with the Relaxation of Share Transfer Norms

    Soon after the rollback of the much criticized aspect of the Consolidated Foreign Direct Investment policy dated October 1, 2011 which treated foreign investments in Indian securities as external commercial borrowings in case such investments conferred options on the foreign investors, the policy makers have brought more good news for the investor community.
    - kanga & co

  • Franchising in India

    In the last two decades, India has witnessed a sea change in its foreign investment policy resulting in it being one of the most preferred investment destinations. With growing globalisation and liberalisation, brand awareness has been created in the Indian masses and today India is the one of the biggest and fastest emerging markets for various businesses across the world. Being geographically vast and culturally diverse, India offers the most favorable franchising environment with a huge consumer market. Franchising in this respect has managed to pick up as a successful business module for local companies in India.
    - kanga & co
© 2018 www.legal500.com